This high binding affinity to MCL-1 translated to cellular efficacy (Table 1), where cell death at subnanomolar concentrations was observed in tumor cell lines derived from MM (AMO-1, H929) and AML (MV4-11). Here, MCL1 is linked to neoplasm.